Early day motion tabled by primary sponsor Lee Scott (Conservative), on Tuesday, 12 June 2007, in the House of Commons. It is signed by 58 members in total.
WET AGE-RELATED MACULAR DEGENERATION TREATMENT WITH LUCENTIS
That this House notes the report in the New England Journal of Medicine that recorded that the drug Lucentis is effective for nine out of 10 patients for the treatment of wet age-related macular degeneration; is concerned that while Scottish patients will receive the drug, many of those in England and Wales will not; and calls on the National Institute for Health and Clinical Excellence to authorise immediately the use of this treatment.
Secondary information
- Type
- Early day motion
- Reference
- 1673
- Session
- 2006-07
- Other sponsors
- Janet Dean
- Martin Caton
- Bob Spink
- Alan Simpson
- Bob Russell
- Subjects
- Drugs Macular degeneration
- Link
- View this Early day motion on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-10-05 13:44:05 +0100
- URI
- http://data.parliament.uk/edms/33487
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/edms/33487
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/edms/33487